The ALS/PDC syndrome of Guam and the cycad hypothesis
- PMID: 18490618
- DOI: 10.1212/01.wnl.0000312571.81091.26
The ALS/PDC syndrome of Guam and the cycad hypothesis
Abstract
There is a high incidence on Guam of a severe tauopathy known as the Parkinson- dementia complex (PDC). It is linked with an even more malignant amyotrophic lateral sclerosis (ALS) syndrome. There is great interest in determining the cause, or causes, of the Guam ALS/PDC syndrome because insight might be gained regarding ALS and the more common tauopathies found throughout the world. Research into the disorder is stimulated by hypotheses as to cause. Such hypotheses should be compatible with the known epidemiology and pathology of the syndrome. These include a high, if not exclusive, restriction to the Chamorro population, familial occurrence, a regional variation on Guam itself, a definite persistence but with declining incidence, and a possible duplication in isolated villages on the Kii peninsula of Japan. Proposed causation factors should also be able to reproduce the syndrome in experimental systems. This includes induction of neurofibrillary tangles with a tau isoform distribution similar to that of Alzheimer disease and association of the lesions with TDP-43 and Lrrk2. A recurring hypothesis as to causation is exposure to Cycas micronesica, the false Sago palm known locally as fadang. We review the reasons why this hypothesis falls short of the minimal criteria needed for further serious consideration and discuss some other possibilities that should not be excluded.
Comment in
-
The ALS/PDC syndrome of Guam and the cycad hypothesis.Neurology. 2009 Feb 3;72(5):473, 476; author reply 475-6. doi: 10.1212/01.wnl.0000344257.59693.cf. Neurology. 2009. PMID: 19188582 No abstract available.
-
The ALS/PDC syndrome of Guam and the cycad hypothesis.Neurology. 2009 Feb 3;72(5):473-4, 476; author reply 475-6. Neurology. 2009. PMID: 19195084 No abstract available.
-
The ALS/PDC syndrome of Guam and the cycad hypothesis.Neurology. 2009 Feb 3;72(5):474, 476; author reply 475-6. Neurology. 2009. PMID: 19195085 No abstract available.
-
The ALS/PDC syndrome of Guam and the cycad hypothesis.Neurology. 2009 Feb 3;72(5):474-6; author reply 475-6. Neurology. 2009. PMID: 19195086 No abstract available.
Similar articles
-
Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?Neuropathol Appl Neurobiol. 2005 Aug;31(4):345-53. doi: 10.1111/j.1365-2990.2005.00686.x. Neuropathol Appl Neurobiol. 2005. PMID: 16008818 Review.
-
[Lessons from Guam ALS/PDC study].Rinsho Shinkeigaku. 2007 Nov;47(11):717-21. Rinsho Shinkeigaku. 2007. PMID: 18210783 Japanese.
-
The ALS/PDC syndrome of Guam and the cycad hypothesis.Neurology. 2009 Feb 3;72(5):473, 476; author reply 475-6. doi: 10.1212/01.wnl.0000344257.59693.cf. Neurology. 2009. PMID: 19188582 No abstract available.
-
The ALS/PDC syndrome of Guam and the cycad hypothesis.Neurology. 2009 Feb 3;72(5):474, 476; author reply 475-6. Neurology. 2009. PMID: 19195085 No abstract available.
-
[Disappearance of ALS from Guam: implications for exogenous causes].Rinsho Shinkeigaku. 1995 Dec;35(12):1549-53. Rinsho Shinkeigaku. 1995. PMID: 8752460 Review. Japanese.
Cited by
-
Rethinking cycad metabolite research.Commun Integr Biol. 2011 Jan;4(1):86-8. doi: 10.4161/cib.4.1.14084. Commun Integr Biol. 2011. PMID: 21509189 Free PMC article.
-
ALS-Plus syndrome: non-pyramidal features in a large ALS cohort.J Neurol Sci. 2014 Oct 15;345(1-2):118-24. doi: 10.1016/j.jns.2014.07.022. Epub 2014 Jul 18. J Neurol Sci. 2014. PMID: 25086858 Free PMC article.
-
Flavin-containing monooxygenase mRNA levels are up-regulated in als brain areas in SOD1-mutant mice.Neurotox Res. 2011 Aug;20(2):150-8. doi: 10.1007/s12640-010-9230-y. Epub 2010 Nov 17. Neurotox Res. 2011. PMID: 21082301
-
Amyotrophic lateral sclerosis: one or multiple causes?Neurol Int. 2011 Jun;3(1):e4. doi: 10.4081/ni.2011.e4. Epub 2011 Apr 29. Neurol Int. 2011. PMID: 21785676 Free PMC article.
-
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.Eur J Neurol. 2009 Mar;16(3):297-309. doi: 10.1111/j.1468-1331.2008.02513.x. Eur J Neurol. 2009. PMID: 19364361 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous